The first CertNDx tests are focused on the detection of bladder cancer with non-invasive urinary and tissue testing methods.
A non-invasive, urine-based bladder cancer assay to identify patients at risk of bladder cancer
> More
CertNDx tests will be offered through Predictive's network of CLIA laboratories.